Stratifying patients for polypharmacy interventions: the case for a new
biomarker?
- Christopher Threapleton
, - Tess Harris,
- Emma Baker
Christopher Threapleton
St George's University Hospitals NHS Foundation Trust
Corresponding Author:cthreapl@sgul.ac.uk
Author ProfileEmma Baker
St George's University Hospitals NHS Foundation Trust
Author Profile26 Aug 2021Submitted to British Journal of Clinical Pharmacology 27 Aug 2021Submission Checks Completed
27 Aug 2021Assigned to Editor
08 Sep 2021Review(s) Completed, Editorial Evaluation Pending
08 Sep 2021Editorial Decision: Accept
Apr 2022Published in British Journal of Clinical Pharmacology volume 88 issue 4 on pages 1515-1517. 10.1111/bcp.15083 
